Untitled

First Page		Document Content
Date: 2013-06-02 18:26:52 Health Pharmaceutical industry Pharmacy Clinical research European Medicines Agency Pharmacovigilance Good manufacturing practice Committee on Safety of Medicines Good Laboratory Practice Pharmaceutical sciences Pharmacology Pharmaceuticals policy		Untitled Add to Reading List Source URL: apps.who.int Download Document from Source Website File Size: 661,42 KB Share Document on Facebook

	Administrative Notice November 25, 2014 Safety Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare To: The committee on safety of medicines DocID: 1rA3l - View Document
	25 SeptemberEMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Assessment report DocID: 15jX8 - View Document
	Drug Utilisation Sub-Committee Outcome Statement 6-7 June 2013 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 78th meeting on 6-7 June[removed]DUSC is a national DocID: YO0q - View Document
	73rd Pharmaceutical Committee- New Regulation on clinical trials, update from EMA DocID: QmV9 - View Document
	JOINT PLENARY MEETING OF THE SCIENTIFIC COMMITTEES LUXEMBOURG JEAN MONNET – ROOM[removed]APRIL 2013: 14H30 DocID: Ob7a - View Document